Christopher Dittus, DO, MPH

Assistant Professor
Clinical Research, Hematology/Oncology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Lecture Description

Dr. Christopher Dittus from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for rare lymphomas for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.

Learning Objectives:

• Discuss which types of lymphoma are considered rare.
• Distinguish why it is important to identify rare lymphomas because of unique diagnostic and therapeutic approaches.
• Explain when it is reasonable to refer a patient with a rare lymphoma to a tertiary care center specializing in the care of these patients.